...
首页> 外文期刊>Circulation journal >Effects of Renin-Angiotensin System Inhibitors on the Occurrence of Acute Kidney Injury Following Off-Pump Coronary Artery Bypass Grafting
【24h】

Effects of Renin-Angiotensin System Inhibitors on the Occurrence of Acute Kidney Injury Following Off-Pump Coronary Artery Bypass Grafting

机译:肾素-血管紧张素系统抑制剂对非体外循环冠状动脉旁路移植术后急性肾损伤发生的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: ?Despite several studies that evaluated the effects of renin-angiotensin system (RAS) inhibitors on postoperative renal function in cardiac surgery patients, no final conclusions are available. The aim of the present study was to determine the effect of RAS inhibitors on renal function following off-pump coronary artery bypass grafting (OPCAB). Methods and Results: ?Among patients who underwent OPCAB, perioperative characteristics, postoperative renal function and incidence of acute kidney injury (AKI) were compared between those who received RAS inhibitors for at least 2 weeks (RASI group, n=296) and those not treated with RAS inhibitors (Control group, n=176). AKI was defined as an increase in serum creatinine >0.3?mg/dl or >50% from baseline. Preoperative comorbidities were more frequent in the RASI group. Operative data were similar. Incidence of postoperative AKI (19.9% vs 20.9%, P=0.815) and of postoperative renal function was comparable between groups. In the adjusted multivariate logistic regression model for propensity scores between groups, diabetes mellitus, preoperative creatinine level and perioperative transfusion were significant risk factors for postoperative AKI, whereas preoperative treatment with RAS inhibitors did not increase the risk. Conclusions: ?Chronic preoperative use of RAS inhibitors did not affect postoperative renal function or increase the risk of postoperative AKI in patients undergoing OPCAB.??( Circ J ?2010; 74: 1852?-?1858)
机译:背景:尽管有几项研究评估了肾素-血管紧张素系统(RAS)抑制剂对心脏手术患者术后肾功能的影响,但尚无最终结论。本研究的目的是确定非体外循环冠状动脉搭桥术(OPCAB)后RAS抑制剂对肾功能的影响。方法和结果:比较接受RAS抑制剂治疗至少2周的患者(RASI组,n = 296)和未接受OPCAB的患者的围手术期特征,术后肾功能和急性肾损伤(AKI)的发生率。用RAS抑制剂治疗(对照组,n = 176)。 AKI被定义为血清肌酐比基线增加> 0.3?mg / dl或> 50%。 RASI组的术前合并症更为常见。手术数据相似。两组之间的术后AKI发生率(19.9%vs 20.9%,P = 0.815)和术后肾功能的发生率相当。在各组之间倾向得分的校正多元对数回归模型中,糖尿病,术前肌酐水平和围手术期输血是术后AKI的重要危险因素,而术前用RAS抑制剂治疗并没有增加危险。结论:“长期术前使用RAS抑制剂不会影响OPCAB患者的术后肾功能或增加术后AKI的风险。”(Circ J,2010; 74:1852--1858)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号